{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:01:18Z","timestamp":1760295678884,"version":"3.37.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1124\/jpet.112.192575","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T04:20:19Z","timestamp":1334118019000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Polyethylene Glycol-Modified Pigment Epithelial-Derived Factor: New Prospects for Treatment of Retinal Neovascularization"],"prefix":"10.1016","volume":"342","author":[{"given":"Yu-Jing","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lv-Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.192575_bib1","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.192575_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.preteyeres.2004.05.002","article-title":"Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential","volume":"23","author":"Barnstable","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1124\/jpet.112.192575_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1471-4914(02)02362-6","article-title":"PEDF: anti-angiogenic guardian of ocular function","volume":"8","author":"Bouck","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.112.192575_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200868080-00002","article-title":"Neovascular age-related macular degeneration: potential therapies","volume":"68","author":"Chappelow","year":"2008","journal-title":"Drugs"},{"key":"10.1124\/jpet.112.192575_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1124\/jpet.112.192575_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/jpet.112.192575_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1124\/jpet.112.192575_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.yapd.2006.04.010","article-title":"Retinopathy of prematurity","volume":"53","author":"Drack","year":"2006","journal-title":"Adv Pediatr"},{"key":"10.1124\/jpet.112.192575_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00024677-200302060-00001","article-title":"Clinical use of pegvisomant for the treatment of acromegaly","volume":"2","author":"Drake","year":"2003","journal-title":"Treat Endocrinol"},{"key":"10.1124\/jpet.112.192575_bib10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diabetes.51.4.1218","article-title":"Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in brown norway and sprague dawley rats contributing to different susceptibilities to retinal neovascularization","volume":"51","author":"Gao","year":"2002","journal-title":"Diabetes"},{"key":"10.1124\/jpet.112.192575_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/eye.2009.324","article-title":"Special features of human retinal angiogenesis","volume":"24","author":"Gariano","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1124\/jpet.112.192575_bib12","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"New Eng J Med"},{"key":"10.1124\/jpet.112.192575_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0169-409X(03)00110-8","article-title":"Pegaspargase: a review of clinical studies","volume":"55","author":"Graham","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.112.192575_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.112.192575_bib15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3892\/or.2012.1621","article-title":"AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits lewis lung carcinoma growth in mice","volume":"27","author":"He","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1124\/jpet.112.192575_bib16","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis","volume":"343","author":"Heathcote","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1124\/jpet.112.192575_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"New Engl J Med"},{"key":"10.1124\/jpet.112.192575_bib18","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1167\/iovs.09-3779","article-title":"Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy","volume":"51","author":"Huang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.112.192575_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/11318550-000000000-00000","article-title":"Current status of vascular endothelial growth factor inhibition in age-related macular degeneration","volume":"24","author":"Mousa","year":"2010","journal-title":"BioDrugs"},{"key":"10.1124\/jpet.112.192575_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1208\/s12248-009-9081-8","article-title":"Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery","volume":"11","author":"Pai","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/jpet.112.192575_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ajpath.2010.10.014","article-title":"Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization","volume":"178","author":"Park","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.112.192575_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200645100-00002","article-title":"Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs","volume":"45","author":"Parveen","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.112.192575_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-005-9046-2","article-title":"Polymer architecture and drug delivery","volume":"23","author":"Qiu","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.112.192575_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1345\/aph.10054","article-title":"Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs","volume":"34","author":"Reddy","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.112.192575_bib25","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.112.192575_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpedsurg.2004.09.049","article-title":"Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth","volume":"40","author":"Streck","year":"2005","journal-title":"J Pediatr Surg"},{"key":"10.1124\/jpet.112.192575_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-4835(91)90248-D","article-title":"PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity","volume":"53","author":"Tombran-Tink","year":"1991","journal-title":"Exp Eye Res"},{"issue":"Suppl 3","key":"10.1124\/jpet.112.192575_bib28","first-page":"S344","article-title":"Polyethylene glycol-interferon: current status in hepatitis C virus therapy","volume":"17","author":"Wedemeyer","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl A","key":"10.1124\/jpet.112.192575_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0305-7372(02)80002-0","article-title":"Novel effects with polyethylene glycol modified pharmaceuticals","volume":"28","author":"Yowell","year":"2002","journal-title":"Cancer Treat Rev"},{"key":"10.1124\/jpet.112.192575_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000072143","article-title":"Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization","volume":"35","author":"Yu","year":"2003","journal-title":"Ophthalmic Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524182481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524182481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.192575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:08:22Z","timestamp":1739984902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524182481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0022356524182481"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.192575","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyethylene Glycol-Modified Pigment Epithelial-Derived Factor: New Prospects for Treatment of Retinal Neovascularization","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.192575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}